These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36031142)
1. Intracellular glutathione levels affect the outcomes of verteporfin-mediated photodynamic therapy in esophageal cancer cells. Edano M; Kanda T; Tarumoto R; Hamamoto W; Hasegawa T; Mae Y; Onoyama T; Takata T; Sugihara T; Isomoto H Photodiagnosis Photodyn Ther; 2022 Dec; 40():103090. PubMed ID: 36031142 [TBL] [Abstract][Full Text] [Related]
2. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma. Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958 [TBL] [Abstract][Full Text] [Related]
3. Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery. Quinlan JA; Inglut CT; Srivastava P; Rahman I; Stabile J; Gaitan B; Arnau Del Valle C; Baumiller K; Gaur A; Chiou WA; Karim B; Connolly N; Robey RW; Woodworth GF; Gottesman MM; Huang HC Adv Sci (Weinh); 2024 May; 11(17):e2302872. PubMed ID: 38445882 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma. Yamashita J; Kimoto A; Teraoka S; Hiraoka Y; Takeda D; Kakei Y; Shigeoka M; Hasegawa T; Akashi M Oral Dis; 2024 Jul; 30(5):3261-3271. PubMed ID: 37890051 [TBL] [Abstract][Full Text] [Related]
5. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment. Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166 [TBL] [Abstract][Full Text] [Related]
6. Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells. Wang XW; Yang ZY; Li T; Zhao XR; Li XZ; Wang XX Mol Biotechnol; 2024 Sep; 66(9):2558-2568. PubMed ID: 37751128 [TBL] [Abstract][Full Text] [Related]
7. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis. Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235 [TBL] [Abstract][Full Text] [Related]
8. X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs. Clement S; Chen W; Deng W; Goldys EM Int J Nanomedicine; 2018; 13():3553-3570. PubMed ID: 29950835 [TBL] [Abstract][Full Text] [Related]
9. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice. Hu Z; Rao B; Chen S; Duanmu J BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis and autophagy induced by DVDMs-PDT on human esophageal cancer Eca-109 cells. Shi Y; Zhang B; Feng X; Qu F; Wang S; Wu L; Wang X; Liu Q; Wang P; Zhang K Photodiagnosis Photodyn Ther; 2018 Dec; 24():198-205. PubMed ID: 30268863 [TBL] [Abstract][Full Text] [Related]
11. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment. Lu J; Roy B; Anderson M; Leggett CL; Levy MJ; Pogue B; Hasan T; Wang KK J Biomed Opt; 2019 Nov; 24(11):1-11. PubMed ID: 31741351 [TBL] [Abstract][Full Text] [Related]
12. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Celli JP; Solban N; Liang A; Pereira SP; Hasan T Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484 [TBL] [Abstract][Full Text] [Related]
13. Nano-Photosensitizer Directed Targeted Phototherapy Effective Against Oral Cancer in Animal Model. Yu L; Zhu G; Zhang Z; Xu Z; Peng W; Zeng L; Yu Y; Wang S; Lin Z; Zhang X; Zhou N; Zhang L; Liang L Int J Nanomedicine; 2023; 18():6185-6198. PubMed ID: 37933297 [TBL] [Abstract][Full Text] [Related]
14. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer. Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634 [TBL] [Abstract][Full Text] [Related]
15. Verteporfin-photodynamic therapy is effective on gastric cancer cells. Mae Y; Kanda T; Sugihara T; Takata T; Kinoshita H; Sakaguchi T; Hasegawa T; Tarumoto R; Edano M; Kurumi H; Ikebuchi Y; Kawaguchi K; Isomoto H Mol Clin Oncol; 2020 Sep; 13(3):10. PubMed ID: 32754324 [TBL] [Abstract][Full Text] [Related]
16. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer. Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R Front Immunol; 2023; 14():1188087. PubMed ID: 38022682 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines. Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764 [TBL] [Abstract][Full Text] [Related]
18. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor. Fateye B; Wan A; Yang X; Myers K; Chen B Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781 [TBL] [Abstract][Full Text] [Related]
19. In vitro effects of verteporfin on ocular cells. Ammar DA; Kahook MY Mol Vis; 2013; 19():424-9. PubMed ID: 23441114 [TBL] [Abstract][Full Text] [Related]